Revenue: The sum of all revenue fields included for a company's operating activities.
Sorrento Therapeutics, Inc. (SRNE) had Revenue of $15.03M for the most recently reported fiscal quarter, ending 2023-06-30.
| Income Statement Financials | |
|
Revenue |
$15.03M |
$-95.21M |
|
$8.45M |
|
$6.57M |
|
$92.26M |
|
$-77.23M |
|
$-30.63M |
|
$-107.86M |
|
$-107.86M |
|
$-108.54M |
|
$-108.54M |
|
$-108.54M |
|
$-108.54M |
|
$-77.23M |
|
$-74.42M |
|
551.28M |
|
551.28M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$133.11M |
|
$53.24M |
|
$323.58M |
|
$456.69M |
|
$264.95M |
|
$21.74M |
|
$389.70M |
|
$654.65M |
|
$-197.96M |
|
$-400.51M |
|
$-197.96M |
|
551.28M |
|
| Cash Flow Statement Financials | |
$-105.12M |
|
$1.54M |
|
$150.01M |
|
$23.63M |
|
$69.75M |
|
$46.12M |
|
$33.48M |
|
$-0.01M |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
-0.12 |
|
-0.72 |
|
43.74% |
|
-514.03% |
|
-514.03% |
|
-- |
|
-717.90% |
|
-633.69% |
|
$-105.34M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.88 |
|
0.46 |
|
196.02 |
|
54.83% |
|
27.10% |
|
-23.77% |
|
61.59% |
|
$-0.36 |
|
$-0.19 |
|
$-0.19 |
|